{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:07:04Z","timestamp":1749874024417,"version":"3.41.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"DOI":"10.7759\/cureus.85936","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:21:13Z","timestamp":1749835273000},"source":"Crossref","is-referenced-by-count":0,"title":["Iron Overload, Clonal Hematopoiesis, and Cancer Risk in Aging and Transfusion-Dependent Populations: A Literature Review"],"prefix":"10.7759","author":[{"given":"Quang D","family":"La","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Faltas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Zavareh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarnum","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzair","family":"Uzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasneel S","family":"Kahlam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal","family":"Revuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmukh","family":"Bachhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Transfusion Iron Overload","author":"Rasel M","year":"2024","unstructured":"Rasel M, Hashmi MF, Mahboobi SK. Transfusion Iron Overload. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s1383-5718(02)00135-3","article-title":"Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A","volume":"519","author":"Glei M","year":"2002","unstructured":"Glei M, Latunde-Dada GO, Klinder A, et al.. Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res. 2002, 519:151-61. 10.1016\/s1383-5718(02)00135-3","journal-title":"Mutat Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.006","article-title":"Survival and complications in thalassemia","volume":"1054","author":"Borgna-Pignatti C","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, et al.. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005, 1054:40-7. 10.1196\/annals.1345.006","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/thalassrep13030017","article-title":"Understanding the intricacies of iron overload associated with \u03b2-thalassemia: a comprehensive review","volume":"13","author":"Basu S","year":"2023","unstructured":"Basu S, Rahaman M, Dolai TK, et al.. Understanding the intricacies of iron overload associated with \u03b2-thalassemia: a comprehensive review. Thalassemia Reports. 2023, 13:179-194. 10.3390\/thalassrep13030017","journal-title":"Thalassemia Reports"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.16339.28969","article-title":"A cross-sectional study on the parental awareness of thalasssemic children","volume":"17","author":"Gul Z","year":"2025","unstructured":"Gul Z, Malik M, Uzair U, et al.. A cross-sectional study on the parental awareness of thalasssemic children. Cureus. 2025, 17:10.13140\/RG.2.2.16339.28969","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70715","article-title":"Awareness about thalassemia among the parents of thalassemic children in Balochistan: a cross-sectional study","volume":"8","author":"Gul Z","year":"2025","unstructured":"Gul Z, Malik M, Uzair U, et al.. Awareness about thalassemia among the parents of thalassemic children in Balochistan: a cross-sectional study. Health Sci Rep. 2025, 8:e70715. 10.1002\/hsr2.70715","journal-title":"Health Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2006.02.005","article-title":"Neurological complications in beta-thalassemia","volume":"28","author":"Zafeiriou DI","year":"2006","unstructured":"Zafeiriou DI, Economou M, Athanasiou-Metaxa M. Neurological complications in beta-thalassemia. Brain Dev. 2006, 28:477-81. 10.1016\/j.braindev.2006.02.005","journal-title":"Brain Dev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.06.002","article-title":"Thalassemia and malignancy: An emerging concern?","volume":"37","author":"Hodroj MH","year":"2019","unstructured":"Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, et al.. Thalassemia and malignancy: An emerging concern?. Blood Rev. 2019, 37:100585. 10.1016\/j.blre.2019.06.002","journal-title":"Blood Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.821014","article-title":"Iron overload induces oxidative stress, cell cycle arrest and apoptosis in chondrocytes","volume":"10","author":"Karim A","year":"2022","unstructured":"Karim A, Bajbouj K, Shafarin J, et al.. Iron overload induces oxidative stress, cell cycle arrest and apoptosis in chondrocytes. Front Cell Dev Biol. 2022, 10:821014. 10.3389\/fcell.2022.821014","journal-title":"Front Cell Dev Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell CS","year":"2021","unstructured":"Marnell CS, Bick A, Natarajan P. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol. 2021, 161:98-105. 10.1016\/j.yjmcc.2021.07.004","journal-title":"J Mol Cell Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02226-6","article-title":"Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche","volume":"38","author":"Winter S","year":"2024","unstructured":"Winter S, G\u00f6tze KS, Hecker JS, et al.. Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche. Leukemia. 2024, 38:936-46. 10.1038\/s41375-024-02226-6","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2021.01.042","article-title":"The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study","volume":"94","author":"Phillips R","year":"2021","unstructured":"Phillips R, Januszewicz W, Pilonis ND, et al.. The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study. Gastrointest Endosc. 2021, 94:263-270.e2. 10.1016\/j.gie.2021.01.042","journal-title":"Gastrointest Endosc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/whr.2019.0011","article-title":"Iron deficiency in menstruating adult women: much more than anemia","volume":"1","author":"Fernandez-Jimenez MC","year":"2020","unstructured":"Fernandez-Jimenez MC, Moreno G, et al.. Iron deficiency in menstruating adult women: much more than anemia. Womens Health Rep (New Rochelle). 2020, 1:26-35. 10.1089\/whr.2019.0011","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165338","article-title":"Changes in iron status biomarkers with advancing age according to sex and menopause: a population-based study","volume":"12","author":"Merlo F","year":"2023","unstructured":"Merlo F, Groothof D, Khatami F, et al.. Changes in iron status biomarkers with advancing age according to sex and menopause: a population-based study. J Clin Med. 2023, 12:10.3390\/jcm12165338","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102778","article-title":"Ferritin - from iron, through inflammation and autoimmunity, to COVID-19","volume":"126","author":"Mahroum N","year":"2022","unstructured":"Mahroum N, Alghory A, Kiyak Z, et al.. Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun. 2022, 126:102778. 10.1016\/j.jaut.2021.102778","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.12074","article-title":"Iron and oxidizing species in oxidative stress and Alzheimer's disease","volume":"2","author":"Zhao Z","year":"2019","unstructured":"Zhao Z. Iron and oxidizing species in oxidative stress and Alzheimer's disease. Aging Med (Milton). 2019, 2:82-7. 10.1002\/agm2.12074","journal-title":"Aging Med (Milton)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010131","article-title":"Oxidative stress in age-related neurodegenerative diseases: an overview of recent tools and findings","volume":"12","author":"Korovesis D","year":"2023","unstructured":"Korovesis D, Rubio-Tom\u00e1s T, Tavernarakis N. Oxidative stress in age-related neurodegenerative diseases: an overview of recent tools and findings. Antioxidants (Basel). 2023, 12:10.3390\/antiox12010131","journal-title":"Antioxidants (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101628","article-title":"Prooxidative chain transfer activity by thiol groups in biological systems","volume":"36","author":"Kunath S","year":"2020","unstructured":"Kunath S, Schindeldecker M, De Giacomo A, et al.. Prooxidative chain transfer activity by thiol groups in biological systems. Redox Biol. 2020, 36:101628. 10.1016\/j.redox.2020.101628","journal-title":"Redox Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(89)91568-4","article-title":"Thiyl radical attack on polyunsaturated fatty acids: a possible route to lipid peroxidation","volume":"161","author":"Sch\u00f6neich C","year":"1989","unstructured":"Sch\u00f6neich C, Asmus KD, Dillinger U, von Bruchhausen F. Thiyl radical attack on polyunsaturated fatty acids: a possible route to lipid peroxidation. Biochem Biophys Res Commun. 1989, 161:113-120. 10.1016\/0006-291x(89)91568-4","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/kin.20404","article-title":"Rate constants and transition-state geometry of reactions of alkyl, alkoxyl, and peroxyl radicals with thiols","volume":"41","author":"Denisov E","year":"2008","unstructured":"Denisov E, Chatgilialoglu C, Shestakov A, Denisova T. Rate constants and transition-state geometry of reactions of alkyl, alkoxyl, and peroxyl radicals with thiols. Int J Chem Kinet. 2008, 41:284-293. 10.1002\/kin.20404","journal-title":"Int J Chem Kinet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1021\/ar0400847","article-title":"Trans lipids: the free radical path","volume":"38","author":"Chatgilialoglu C","year":"2005","unstructured":"Chatgilialoglu C, Ferreri C. Trans lipids: the free radical path. Acc Chem Res. 2005, 38:441-8. 10.1021\/ar0400847","journal-title":"Acc Chem Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1021\/tx049856y","article-title":"Thiyl radical reaction with amino acid side chains: rate constants for hydrogen transfer and relevance for posttranslational protein modification","volume":"17","author":"Nauser T","year":"2004","unstructured":"Nauser T, Pelling J, Sch\u00f6neich C. Thiyl radical reaction with amino acid side chains: rate constants for hydrogen transfer and relevance for posttranslational protein modification. Chem Res Toxicol. 2004, 17:1323-8. 10.1021\/tx049856y","journal-title":"Chem Res Toxicol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2021.05.001","article-title":"Iron metabolism: pathophysiology and pharmacology","volume":"42","author":"Roemhild K","year":"2021","unstructured":"Roemhild K, von Maltzahn F, Weiskirchen R, et al.. Iron metabolism: pathophysiology and pharmacology. Trends Pharmacol Sci. 2021, 42:640-56. 10.1016\/j.tips.2021.05.001","journal-title":"Trends Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1535370220953065","article-title":"Overdosing on iron: elevated iron and degenerative brain disorders","volume":"245","author":"D'Mello SR","year":"2020","unstructured":"D'Mello SR, Kindy MC. Overdosing on iron: elevated iron and degenerative brain disorders. Exp Biol Med (Maywood). 2020, 245:1444-73. 10.1177\/1535370220953065","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000343856","article-title":"Hepatic iron overload and hepatocellular carcinoma","volume":"3","author":"Kew MC","year":"2014","unstructured":"Kew MC. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer. 2014, 3:31-40. 10.1159\/000343856","journal-title":"Liver Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone M","year":"2018","unstructured":"Masarone M, Rosato V, Dallio M, et al.. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018, 2018:9547613. 10.1155\/2018\/9547613","journal-title":"Oxid Med Cell Longev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis A","year":"2009","unstructured":"Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009, 27:120-39. 10.1080\/10590500902885684","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2011.477","article-title":"8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome","volume":"3","author":"Li S","year":"2012","unstructured":"Li S, Wang X, Wu Y, et al.. 8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome. Oncol Lett. 2012, 3:338-42. 10.3892\/ol.2011.477","journal-title":"Oncol Lett"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06277.x","article-title":"Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease","volume":"135","author":"Walter PB","year":"2006","unstructured":"Walter PB, Fung EB, Killilea DW, et al.. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006, 135:254-63. 10.1111\/j.1365-2141.2006.06277.x","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2013.875514","article-title":"Interplay between DNA repair and inflammation, and the link to cancer","volume":"49","author":"Kidane D","year":"2014","unstructured":"Kidane D, Chae WJ, Czochor J, et al.. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014, 49:116-39. 10.3109\/10409238.2013.875514","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao H","year":"2021","unstructured":"Zhao H, Wu L, Yan G, et al.. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021, 6:263. 10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03034-7","article-title":"Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages","volume":"19","author":"Sun JL","year":"2021","unstructured":"Sun JL, Zhang NP, Xu RC, et al.. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. J Transl Med. 2021, 19:347. 10.1186\/s12967-021-03034-7","journal-title":"J Transl Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122591","article-title":"Iron: an essential element of cancer metabolism","volume":"9","author":"Hsu MY","year":"2020","unstructured":"Hsu MY, Mina E, Roetto A, Porporato PE. Iron: an essential element of cancer metabolism. Cells. 2020, 9:10.3390\/cells9122591","journal-title":"Cells"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00476","article-title":"Altered iron metabolism and impact in cancer biology, metastasis, and immunology","volume":"10","author":"Brown RA","year":"2020","unstructured":"Brown RA, Richardson KL, Kabir TD, et al.. Altered iron metabolism and impact in cancer biology, metastasis, and immunology. Front Oncol. 2020, 10:476. 10.3389\/fonc.2020.00476","journal-title":"Front Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10607-9","article-title":"Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway","volume":"18","author":"Wang F","year":"2024","unstructured":"Wang F, Xu WQ, Zhang WQ, et al.. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway. Hepatol Int. 2024, 18:636-50. 10.1007\/s12072-023-10607-9","journal-title":"Hepatol Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86486-x","article-title":"Iron metabolism in a mouse model of hepatocellular carcinoma","volume":"15","author":"Yilmaz D","year":"2025","unstructured":"Yilmaz D, Tharehalli U, Paganoni R, et al.. Iron metabolism in a mouse model of hepatocellular carcinoma. Sci Rep. 2025, 15:2180. 10.1038\/s41598-025-86486-x","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.12.028","article-title":"Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer","volume":"50","author":"Jian J","year":"2011","unstructured":"Jian J, Yang Q, Dai J, et al.. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med. 2011, 50:841-7. 10.1016\/j.freeradbiomed.2010.12.028","journal-title":"Free Radic Biol Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16640","article-title":"The transfusion management of beta thalassemia in the United States","volume":"61","author":"Lal A","year":"2021","unstructured":"Lal A, Wong T, Keel S, et al.. The transfusion management of beta thalassemia in the United States. Transfusion. 2021, 61:3027-39. 10.1111\/trf.16640","journal-title":"Transfusion"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-370098","article-title":"How I treat transfusional iron overload","volume":"120","author":"Hoffbrand AV","year":"2012","unstructured":"Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood. 2012, 120:3657-69. 10.1182\/blood-2012-05-370098","journal-title":"Blood"},{"key":"ref40","article-title":"Iron overload in Beta thalassaemia major and intermedia patients","volume":"8","author":"Mishra AK","year":"2013","unstructured":"Mishra AK, Tiwari A.. Iron overload in Beta thalassaemia major and intermedia patients. Maedica (Bucur). 2013, 8:328-332.","journal-title":"Maedica (Bucur)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000036","article-title":"Iron overload in transfusion-dependent patients","volume":"2019","author":"Coates TD","year":"2019","unstructured":"Coates TD. Iron overload in transfusion-dependent patients. Hematology Am Soc Hematol Educ Program. 2019, 2019:337-44. 10.1182\/hematology.2019000036","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot P","year":"2012","unstructured":"Brissot P, Ropert M, Le Lan C, Lor\u00e9al O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012, 1820:403-10. 10.1016\/j.bbagen.2011.07.014","journal-title":"Biochim Biophys Acta"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4911205","article-title":"Iron chelators in treatment of iron overload","volume":"2022","author":"Entezari S","year":"2022","unstructured":"Entezari S, Haghi SM, Norouzkhani N, et al.. Iron chelators in treatment of iron overload. J Toxicol. 2022, 2022:4911205. 10.1155\/2022\/4911205","journal-title":"J Toxicol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077342","article-title":"Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent \u03b2-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial","volume":"14","author":"Premawardhena A","year":"2024","unstructured":"Premawardhena A, Perera C, Wijethilaka MN, et al.. Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent \u03b2-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial. BMJ Open. 2024, 14:e077342. 10.1136\/bmjopen-2023-077342","journal-title":"BMJ Open"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2021.100357","article-title":"Quantitative T2* imaging of iron overload in a non-dedicated center - Normal variation, repeatability and reader variation","volume":"8","author":"Lid\u00e9n M","year":"2021","unstructured":"Lid\u00e9n M, Adrian D, Widell J, et al.. Quantitative T2* imaging of iron overload in a non-dedicated center - Normal variation, repeatability and reader variation. Eur J Radiol Open. 2021, 8:100357. 10.1016\/j.ejro.2021.100357","journal-title":"Eur J Radiol Open"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal S","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019, 366:10.1126\/science.aan4673","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000991","article-title":"Clonal hematopoiesis and risk for hematologic malignancy","volume":"136","author":"Warren JT","year":"2020","unstructured":"Warren JT, Link DC. Clonal hematopoiesis and risk for hematologic malignancy. Blood. 2020, 136:1599-605. 10.1182\/blood.2019000991","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02253-3","article-title":"Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer","volume":"38","author":"Arends CM","year":"2024","unstructured":"Arends CM, Kopp K, Hablesreiter R, et al.. Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia. 2024, 38:1378-89. 10.1038\/s41375-024-02253-3","journal-title":"Leukemia"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205404","article-title":"Exploring clonal hematopoiesis and its impact on aging, cancer, and patient care","volume":"15","author":"Rodriguez JE","year":"2023","unstructured":"Rodriguez JE, Micol JB, Baldini C. Exploring clonal hematopoiesis and its impact on aging, cancer, and patient care. Aging (Albany NY). 2023, 15:14507-8. 10.18632\/aging.205404","journal-title":"Aging (Albany NY)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316646","article-title":"Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up","volume":"118","author":"Cappellini MD","year":"2011","unstructured":"Cappellini MD, Bejaoui M, Agaoglu L, et al.. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood. 2011, 118:884-93. 10.1182\/blood-2010-11-316646","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v15i1.5247","article-title":"Adherence to iron chelation therapy and its determinants","volume":"15","author":"Sidhu S","year":"2021","unstructured":"Sidhu S, Kakkar S, Dewan P, et al.. Adherence to iron chelation therapy and its determinants. Int J Hematol Oncol Stem Cell Res. 2021, 15:27-34. 10.18502\/ijhoscr.v15i1.5247","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-023-02221-y","article-title":"The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review","volume":"22","author":"Lee WJ","year":"2024","unstructured":"Lee WJ, Mohd Tahir NA, Chun GY, Li SC. The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review. Health Qual Life Outcomes. 2024, 22:14. 10.1186\/s12955-023-02221-y","journal-title":"Health Qual Life Outcomes"},{"key":"ref53","unstructured":"Northern California Comprehensive Thalassemia Center. Iron overload and chelation therapy. (2025). Accessed: May 25, 2025: https:\/\/thalassemia.ucsf.edu\/iron-overload-and-chelation-therapy."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2450\/2011.0098-10","article-title":"Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination","volume":"9","author":"Masera N","year":"2011","unstructured":"Masera N, Tavecchia L, Longoni DV, et al.. Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination. Blood Transfus. 2011, 9:462-5. 10.2450\/2011.0098-10","journal-title":"Blood Transfus"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11072010","article-title":"Safety and efficacy of the new combination iron chelation regimens in patients with transfusion-dependent thalassemia and severe iron overload","volume":"11","author":"Origa R","year":"2022","unstructured":"Origa R, Cinus M, Pilia MP, et al.. Safety and efficacy of the new combination iron chelation regimens in patients with transfusion-dependent thalassemia and severe iron overload. J Clin Med. 2022, 11:10.3390\/jcm11072010","journal-title":"J Clin Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe CN","year":"2016","unstructured":"Kontoghiorghe CN, Kontoghiorghes GJ. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. Drug Des Devel Ther. 2016, 10:465-81. 10.2147\/DDDT.S79458","journal-title":"Drug Des Devel Ther"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.035","article-title":"Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives","volume":"125","author":"Elmberg M","year":"2003","unstructured":"Elmberg M, Hultcrantz R, Ekbom A, et al.. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology. 2003, 125:1733-41. 10.1053\/j.gastro.2003.09.035","journal-title":"Gastroenterology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2003.08.023","article-title":"Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal","volume":"533","author":"Huang X","year":"2003","unstructured":"Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res. 2003, 533:153-71. 10.1016\/j.mrfmmm.2003.08.023","journal-title":"Mutat Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0733","article-title":"Iron and cancer risk--a systematic review and meta-analysis of the epidemiological evidence","volume":"23","author":"Fonseca-Nunes A","year":"2014","unstructured":"Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk--a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014, 23:12-31. 10.1158\/1055-9965.EPI-13-0733","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.627662","article-title":"The clinical significance of iron overload and iron metabolism in myelodysplastic syndrome and acute myeloid leukemia","volume":"11","author":"Weber S","year":"2020","unstructured":"Weber S, Parmon A, Kurrle N, et al.. The clinical significance of iron overload and iron metabolism in myelodysplastic syndrome and acute myeloid leukemia. Front Immunol. 2020, 11:627662. 10.3389\/fimmu.2020.627662","journal-title":"Front Immunol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.04.006","article-title":"Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic","volume":"39","author":"Masini E","year":"2005","unstructured":"Masini E, Bani D, Vannacci A, et al.. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic Biol Med. 2005, 39:520-31. 10.1016\/j.freeradbiomed.2005.04.006","journal-title":"Free Radic Biol Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ircmb.2018.05.006","article-title":"Mitochondria and reactive oxygen species in aging and age-related diseases","volume":"340","author":"Giorgi C","year":"2018","unstructured":"Giorgi C, Marchi S, Simoes IC, et al.. Mitochondria and reactive oxygen species in aging and age-related diseases. Int Rev Cell Mol Biol. 2018, 340:209-344. 10.1016\/bs.ircmb.2018.05.006","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158447","article-title":"Mitochondrial dysfunction in cell senescence and aging","volume":"132","author":"Miwa S","year":"2022","unstructured":"Miwa S, Kashyap S, Chini E, von Zglinicki T. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest. 2022, 132:10.1172\/JCI158447","journal-title":"J Clin Invest"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2472871","article-title":"Role of iron in brain development, aging, and neurodegenerative diseases","volume":"57","author":"Gao Q","year":"2025","unstructured":"Gao Q, Zhou Y, Chen Y, et al.. Role of iron in brain development, aging, and neurodegenerative diseases. Ann Med. 2025, 57:2472871. 10.1080\/07853890.2025.2472871","journal-title":"Ann Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella C","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020, 105:260-72. 10.3324\/haematol.2019.232124","journal-title":"Haematologica"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101510","article-title":"Iron homeostasis and organismal aging","volume":"72","author":"Zeidan RS","year":"2021","unstructured":"Zeidan RS, Han SM, Leeuwenburgh C, Xiao R. Iron homeostasis and organismal aging. Ageing Res Rev. 2021, 72:101510. 10.1016\/j.arr.2021.101510","journal-title":"Ageing Res Rev"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073612","article-title":"Iron metabolism in aging and age-related diseases","volume":"23","author":"Tian Y","year":"2022","unstructured":"Tian Y, Tian Y, Yuan Z, et al.. Iron metabolism in aging and age-related diseases. Int J Mol Sci. 2022, 23:10.3390\/ijms23073612","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376991-iron-overload-clonal-hematopoiesis-and-cancer-risk-in-aging-and-transfusion-dependent-populations-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:21:14Z","timestamp":1749835274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376991-iron-overload-clonal-hematopoiesis-and-cancer-risk-in-aging-and-transfusion-dependent-populations-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":67,"URL":"https:\/\/doi.org\/10.7759\/cureus.85936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}